Free Trial
OTCMKTS:RCDTF

Recordati Industria Chimica E Farmaceutica Q4 2025 Earnings Results & Report

Recordati Industria Chimica E Farmaceutica logo
$58.79 0.00 (0.00%)
As of 11/13/2026

Recordati Industria Chimica E Farmaceutica beat analyst earnings expectations but missed on revenue in its Q4 2025 results, released March 31, 2026. The company reported EPS of $0.88 versus the $0.8570 consensus estimate, while revenue of $770.90 million fell short of the $778.42 million estimate by $7.52 million.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Recordati Industria Chimica E Farmaceutica EPS Results

Actual EPS
$0.88
Consensus EPS
$0.8570
Beat/Miss
Beat by +$0.0230
One Year Ago EPS
N/A

Recordati Industria Chimica E Farmaceutica Revenue Results

Actual Revenue
$770.90 million
Expected Revenue
$778.42 million
Beat/Miss
Missed by -$7.52 million
YoY Revenue Growth
N/A

Conference Call Resources

Recordati Industria Chimica E Farmaceutica Q4 2025 Earnings FAQ

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) reported earnings of $0.88 per share for Q4 2025, beating the consensus estimate of $0.8570. The report was announced on Tuesday, March 31, 2026.

Recordati Industria Chimica E Farmaceutica reported revenue of $770.90 million for Q4 2025, against a consensus estimate of $778.42 million.

Recordati Industria Chimica E Farmaceutica Earnings Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Respighi BidCo Raises Recordati Stake Above 74%
See More Recordati Industria Chimica E Farmaceutica Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Recordati Industria Chimica E Farmaceutica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Recordati Industria Chimica E Farmaceutica and other key companies, straight to your email.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) is an Italian pharmaceutical company founded in 1926 and headquartered in Milan. It develops, manufactures and commercializes medicines, with businesses spanning specialty and primary-care treatments as well as medicines for rare diseases.

Its products address a range of therapeutic areas, including endocrinology, urology, cardiovascular medicine and other specialist fields. Through its rare-disease business, Recordati also provides treatments for patients with uncommon and complex conditions.

The company serves markets in Europe and other regions worldwide, selling its medicines through its own commercial operations and partners. Its international business has expanded over time through acquisitions, including the addition of EUSA Pharma, which strengthened its rare-disease portfolio.

View Recordati Industria Chimica E Farmaceutica Profile